The 36-month beta value for LFMD is also noteworthy at 2.43. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for LFMD is 36.15M, and at present, short sellers hold a 9.71% of that float. The average trading volume of LFMD on June 18, 2025 was 1.67M shares.
LFMD) stock’s latest price update
LifeMD Inc (NASDAQ: LFMD) has seen a rise in its stock price by 9.28 in relation to its previous close of 13.58. However, the company has experienced a 17.50% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-09 that NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled “Direct to Consumer vs.
LFMD’s Market Performance
LifeMD Inc (LFMD) has seen a 17.50% rise in stock performance for the week, with a 40.26% gain in the past month and a 159.44% surge in the past quarter. The volatility ratio for the week is 4.17%, and the volatility levels for the past 30 days are at 3.30% for LFMD. The simple moving average for the past 20 days is 19.97% for LFMD’s stock, with a 133.31% simple moving average for the past 200 days.
Analysts’ Opinion of LFMD
Lake Street, on the other hand, stated in their research note that they expect to see LFMD reach a price target of $12. The rating they have provided for LFMD stocks is “Buy” according to the report published on December 10th, 2024.
Mizuho gave a rating of “Neutral” to LFMD, setting the target price at $7 in the report published on December 04th of the previous year.
LFMD Trading at 60.63% from the 50-Day Moving Average
After a stumble in the market that brought LFMD to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 4.51% of gains for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFMD starting from Yecies Eric Harold, who sale 15,000 shares at the price of $12.25 back on Jun 13 ’25. After this action, Yecies Eric Harold now owns 16,100 shares of LifeMD Inc, valued at $183,750 using the latest closing price.
Galluppi Stefan, the Chief Innovation Officer of LifeMD Inc, sale 85,000 shares at $12.38 during a trade that took place back on Jun 13 ’25, which means that Galluppi Stefan is holding 80,449 shares at $1,052,657 based on the most recent closing price.
Stock Fundamentals for LFMD
Current profitability levels for the company are sitting at:
- 0.0 for the present operating margin
- 0.92 for the gross margin
The net margin for LifeMD Inc stands at -0.05. The total capital return value is set at 0.01.
Based on LifeMD Inc (LFMD), the company’s capital structure generated 1.1 points at debt to capital in total, while cash flow to debt ratio is standing at 0.61. The debt to equity ratio resting at -10.78. The interest coverage ratio of the stock is 0.04.
Currently, EBITDA for the company is -6.65 million with net debt to EBITDA at -3.55. When we switch over and look at the enterprise to sales, we see a ratio of 3.04. The receivables turnover for the company is 21.67for trailing twelve months and the total asset turnover is 3.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.82.
Conclusion
In summary, LifeMD Inc (LFMD) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
